COVID-19 Updates

Last updated: January 22, 2021

This webpage has been created to share the answers to COVID-19-related questions. It will be updated frequently. See below for HS IRBs communications regarding COVID-19.

  • UW-Madison is providing its COVID-19 updates here.
  • Guidance on tools for exchanging and/or storing protected health information (PHI) can be found at the bottom of the HIPAA page. If you have question about this guidance, please contact your HIPAA security and privacy coordinator for assistance.
  • COVID-19 related-guidance for clinical trials research can be found here.
  • Research and Sponsored Programs (RSP) also has information on COVID-19’s impact on sponsored research, including links to federal agencies.
  • The Pharmaceutical Research Center (PRC)'s FAQ can be found here.

Information for Researchers Planning Covid-19 Related Research or Treatment

Mandatory Pause Considerations for On-going Research

New Information Reports and Changes of Protocol

FAQs for Restarting Face-to-Face Research

Keywords:coronavirus, covid-19 research, remote visit, single patient emergency use, expanded access, subject safety, IRB operations, halt enrollment, enrollment, relying site, reliant, reliance, external IRB   Doc ID:98594
Owner:Monica E.Group:Health Sciences IRBs
Created:2020-03-10 10:56 CDTUpdated:2021-01-22 08:51 CDT
Sites:Health Sciences IRBs
Feedback:  0   0